强生将携四款处方药入驻特朗普Rx平台


2026年4月24日 / 美国东部时间下午4:31 / 哥伦比亚广播公司(CBS)新闻

作者:奥利维亚·里纳尔迪

奥利维亚·里纳尔迪 白宫记者

奥利维亚·里纳尔迪是哥伦比亚广播公司新闻的白宫记者。她曾报道特朗普总统2024年竞选活动,此前还曾担任《哥伦比亚广播公司晚间新闻与诺拉·奥唐奈同播》的副制片人,以及《面向全国》节目广播助理。她的办公地点位于华盛顿特区。

查看完整简介
奥利维亚·里纳尔迪

哥伦比亚广播公司新闻独家获悉,制药巨头强生公司将于周五正式在特朗普政府的特朗普Rx平台上推广其四款药物。

该制药公司今年1月宣布,已与特朗普政府达成一项自愿协议,通过为美国民众提供可负担的医保处方药准入渠道、并在特朗普Rx平台上推广其药品,来降低民众用药成本,以此换取豁免总统的关税政策。

白宫折扣药品网站上上架的药物之一是二甲双胍,这是一款治疗2型糖尿病的常用处方药。其余三款分别为二甲双胍缓释片、另一款糖尿病治疗药物卡格列净(Invokana),以及血液稀释剂利伐沙班(Xarelto)。

强生此前已同意在宾夕法尼亚州和北卡罗来纳州投资550亿美元用于研发和生产基地建设。

强生制药产品入驻特朗普Rx平台后,该平台自今年2月上线以来的上架药品数量已增长了一倍多。

不过,该平台上的处方药价格仅面向未参保、或保险不覆盖该药且需全额自费的患者。有保险的患者通常已能享受到更低的药价。

Johnson & Johnson to launch on TrumpRx with 4 of its prescription drugs

April 24, 2026 / 4:31 PM EDT / CBS News

By Olivia Rinaldi

Olivia Rinaldi White House reporter

Olivia Rinaldi is a White House reporter at CBS News. She covered President Trump’s 2024 presidential campaign and was previously an associate producer for “CBS Evening News with Norah O’Donnell” and a broadcast associate for “Face the Nation.” She is based in Washington, D.C.

Read Full Bio

Olivia Rinaldi

Drug-making giant Johnson & Johnson will officially start marketing four of its medications on the Trump administration’s TrumpRx website on Friday, CBS News exclusively learned.

The pharmaceutical company announced in January that it had entered into a voluntary agreement with the Trump administration to lower costs for Americans by providing Medicaid access to affordable prescriptions and marketing its drugs on TrumpRx in exchange for exemption from the president’s tariff agenda.

One of the drugs offered on White House’s discounted pharmaceutical site is metformin, a popular prescription to treat Type 2 diabetes. The others are metformin extended relief; Invokana, another diabetes medication; and Xarelto, a blood thinner.

Johnson & Johnson previously agreed to invest $55 billion in research and production sites in Pennsylvania and North Carolina.

The addition of Johnson & Johnson pharmaceuticals to the TrumpRx site means the administration has more than doubled the number of drugs featured on the low-cost site since it first launched in February.

The prescription drug prices on the site, however, are only available to patients who are uninsured, or whose insurance doesn’t cover it, and who must pay the full list price out of pocket. Those with insurance coverage generally pay lower prices already.

评论

发表回复

您的邮箱地址不会被公开。 必填项已用 * 标注